Skip to Main Content
Table 3—

HbA1c, age, duration of diabetes, and percentage male in groups of patients with diabetes who have had hypoglycemic (hypo) events and those who have not had hypoglycemia (no hypo)

TreatmentnHbA1c (%)Age (years)Duration of diabetes (years)BMI (kg/m2)Sex (% male)
Type 1: no hypo Insulin 908 7.93 (7.76–8.10) 32.8 (31.8–33.8) 16.7 (15.8–17.7) 24.7 (24.4–25.0) 56.1 
Type 1: hypo Insulin 69 7.77 (7.29–8.25) 37.7 (34.1–41.3) 20.7 (17.7–23.7) 25.0 (24.3–25.7) 66.7 
P   0.533 0.009 0.013 0.557 0.078 
        
Type 2: no hypo Insulin 835 8.23 (8.09–8.37) 63.2 (62.4–64.1) 11.8 (11.2–12.4) 30.1 (29.4–30.8) 47.7 
Type 2: hypo Insulin 66 7.87 (7.47–8.28) 66.6 (63.5–69.6) 13.5 (11.3–15.8) 26.7 (25.7–27.7) 47.0 
P   0.097 0.038 0.137 <0.001 0.914 
        
Type 2: no hypo Sulphonylurea tablets 2,800 7.16 (7.08–7.23) 65.4 (65.0–65.9) 6.3 (6.0–6.5) 29.6 (29.5–29.7) 52.2 
Type 2: hypo Sulphonylurea tablets 23 8.00 (7.10–8.91) 65.0 (59.1–70.9) 7.2 (4.3–10.0) 28.1 (26.7–29.5) 47.8 
P   0.064 0.884 0.517 0.122 0.687 
        
All diabetes: no hypo All therapies 8,495 7.19 (7.14–7.24) 62.3 (61.9–62.6) 8.9 (8.6–9.2) 29.0 (28.9–29.1) 52.6 
All diabetes: hypo All therapies 160 7.85 (7.57–8.14) 53.8 (50.8–56.9) 15.6 (13.8–17.4) 26.1 (25.5–26.7) 55.6 
P   <0.001 <0.001 <0.001 <0.001 0.454 
TreatmentnHbA1c (%)Age (years)Duration of diabetes (years)BMI (kg/m2)Sex (% male)
Type 1: no hypo Insulin 908 7.93 (7.76–8.10) 32.8 (31.8–33.8) 16.7 (15.8–17.7) 24.7 (24.4–25.0) 56.1 
Type 1: hypo Insulin 69 7.77 (7.29–8.25) 37.7 (34.1–41.3) 20.7 (17.7–23.7) 25.0 (24.3–25.7) 66.7 
P   0.533 0.009 0.013 0.557 0.078 
        
Type 2: no hypo Insulin 835 8.23 (8.09–8.37) 63.2 (62.4–64.1) 11.8 (11.2–12.4) 30.1 (29.4–30.8) 47.7 
Type 2: hypo Insulin 66 7.87 (7.47–8.28) 66.6 (63.5–69.6) 13.5 (11.3–15.8) 26.7 (25.7–27.7) 47.0 
P   0.097 0.038 0.137 <0.001 0.914 
        
Type 2: no hypo Sulphonylurea tablets 2,800 7.16 (7.08–7.23) 65.4 (65.0–65.9) 6.3 (6.0–6.5) 29.6 (29.5–29.7) 52.2 
Type 2: hypo Sulphonylurea tablets 23 8.00 (7.10–8.91) 65.0 (59.1–70.9) 7.2 (4.3–10.0) 28.1 (26.7–29.5) 47.8 
P   0.064 0.884 0.517 0.122 0.687 
        
All diabetes: no hypo All therapies 8,495 7.19 (7.14–7.24) 62.3 (61.9–62.6) 8.9 (8.6–9.2) 29.0 (28.9–29.1) 52.6 
All diabetes: hypo All therapies 160 7.85 (7.57–8.14) 53.8 (50.8–56.9) 15.6 (13.8–17.4) 26.1 (25.5–26.7) 55.6 
P   <0.001 <0.001 <0.001 <0.001 0.454 

Data are mean (95% CI). The study groups include patients with type 1 diabetes, those with type 2 diabetes treated with insulin, and those with type 2 diabetes treated with tablets. Additionally patients have been analyzed as an overall combined group.

Close Modal

or Create an Account

Close Modal
Close Modal